ITGR
ITGR
US45826H1095
Integer Holdings Corporation
Loading chart...

Company Profile

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Latest News

Related stocks

HAE
HAE • United States
Haemonetics Corporation
118.69 USD
5.4B USD 1Y +134.3%
ALMR
ALMR • United States
Alamar Biosciences, Inc.
25.27 USD
1.75B USD
GKOS
GKOS • United States
Glaukos Corporation
165.69 USD
9.77B USD 1Y +84.1%
INSP
INSP • United States
Inspire Medical Systems, Inc.
68.89 USD
1.99B USD 1Y -15.1%
PEN
PEN • United States
Penumbra, Inc.
319.4 USD
12.58B USD 1Y +22.6%
ATEC
ATEC • United States
Alphatec Holdings, Inc.
10.67 USD
1.64B USD 1Y -26.2%
UFPT
UFPT • United States
UFP Technologies, Inc.
288.97 USD
2.24B USD 1Y +45.9%
GMED
GMED • United States
Globus Medical, Inc.
74.65 USD
10.02B USD 1Y +21.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
35.3% p.a.
Max Drawdown (5Y)
-56.1%
Sharpe Ratio (5Y)
0.13
Beta Factor
0.58
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (35.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -56.1% in the extended horizon.
ende